Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astonea Labs's book value per share for the quarter that ended in Mar. 2026 was ₹54.35.
During the past 12 months, Astonea Labs's average Book Value Per Share Growth Rate was 210.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 91.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Astonea Labs was 91.30% per year. The lowest was 34.90% per year. And the median was 63.10% per year.
Astonea Labs's current price is ₹289.00. Its book value per share for the quarter that ended in Mar. 2026 was ₹54.35. Hence, today's PB Ratio of Astonea Labs is 5.32.
During the past 5 years, the highest P/B Ratio of Astonea Labs was 10.41. The lowest was 2.79. And the median was 4.18.
Astonea Labs (BOM:544409) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Astonea Labs Book Value per Share Related Terms
Astonea Labs Book Value per Share Historical Data
* Premium members only.
The historical data trend for Astonea Labs's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544409 vs ZTS: Book Value per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Astonea Labs's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astonea Labs PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Astonea Labs's PB Ratio distribution charts can be found below:
* The bar in red indicates where Astonea Labs's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astonea Labs (BOM:544409) has a Book Value per Share of ₹54.35 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Astonea Labs and its competitors.
Is Astonea Labs' Book Value per Share too high?
Astonea Labs' current Book Value per Share is ₹54.35. Overall, Astonea Labs has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Astonea Labs' Book Value per Share compare to ZTS?
Astonea Labs' Book Value per Share of ₹54.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Astonea Labs and its competitors. Astonea Labs's current Book Value per Share is ₹54.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astonea Labs stock overvalued right now?
Astonea Labs (BOM:544409) has a current Book Value per Share of ₹54.35. The current Book Value per Share is ₹54.35. Astonea Labs' overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Astonea Labs (BOM:544409), the current Book Value per Share is ₹54.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Astonea Labs Ltd is an India-based pharmaceutical and cosmetics company engaged in the manufacturing and development of healthcare and personal care products. The Company operates in the pharmaceuticals and cosmetics & personal care space, offering products that include generic medicines, OTC products, specialty therapeutics, nutraceuticals, and biosimilars, as well as skincare, haircare, anti-aging, ethical, and organic cosmetic products, supported by in-house research and development and contract manufacturing services. Its business activities are organized across key segments comprising Pharmaceuticals, Cosmetics & Personal Care, R&D & Innovation, and Contract Manufacturing (CDMO).
15GF Score
Get the complete analysis for BOM:544409
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544409 has been successfully added to your 
